[6个月以下儿童接种尼塞韦单抗对呼吸道合胞病毒感染的免疫在成人人群中的影响] - Suppr

[Impact in the adult population of immunization with nirsevimab in children under 6 months of age against respiratory syncytial virus].

作者信息

Reina J, Viana-Ramirez J

机构信息

Jordi Reina, Unidad de Virología. Servicio de Microbiología. Hospital Universitario Son Espases. Carretera de Valldemossa 79. 07120 Palma de Mallorca. Spain.

出版信息

Rev Esp Quimioter. 2024 Dec;37(6):512-514. doi: 10.37201/req/049.2024. Epub 2024 Jul 16.

DOI:10.37201/req/049.2024

PMID:39010814

原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11578431/

Abstract

摘要

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/158e/11578431/ed1a022061da/revespquimioter-37-512-g001.jpg

相似文献

[Impact in the adult population of immunization with nirsevimab in children under 6 months of age against respiratory syncytial virus].[6个月以下儿童接种尼塞韦单抗对呼吸道合胞病毒感染的免疫在成人人群中的影响]

Rev Esp Quimioter. 2024 Dec;37(6):512-514. doi: 10.37201/req/049.2024. Epub 2024 Jul 16.

Early Estimate of Nirsevimab Effectiveness for Prevention of Respiratory Syncytial Virus-Associated Hospitalization Among Infants Entering Their First Respiratory Syncytial Virus Season - New Vaccine Surveillance Network, October 2023-February 2024.2023 年 10 月至 2024 年 2 月，新疫苗监测网络对婴儿进入首个呼吸道合胞病毒季节时，尼赛珠单抗预防呼吸道合胞病毒相关住院的早期效果评估。

MMWR Morb Mortal Wkly Rep. 2024 Mar 7;73(9):209-214. doi: 10.15585/mmwr.mm7309a4.

Implementation of the first respiratory syncytial (RSV) immunization campaign with nirsevimab in an autonomous community in Spain.在西班牙的一个自治区实施首个人呼吸道合胞病毒（RSV）免疫接种活动，使用 nirsevimab。

Hum Vaccin Immunother. 2024 Dec 31;20(1):2365804. doi: 10.1080/21645515.2024.2365804. Epub 2024 Jun 18.

Parental knowledge on the respiratory syncytial virus before the nirsevimab immunization program: Attitudes toward immunization in an autonomous community of Spain.父母在接受 nirsevimab 免疫计划前对呼吸道合胞病毒的了解：西班牙一个自治区的免疫态度。

Hum Vaccin Immunother. 2024 Dec 31;20(1):2357439. doi: 10.1080/21645515.2024.2357439. Epub 2024 Jun 10.

Nirsevimab Immunization to Prevent Respiratory Syncytial Virus-Associated Lower Respiratory Tract Infections in Infants and Children up to 24 Months of Age.尼氏病毒单抗免疫接种预防婴儿和儿童呼吸道合胞病毒相关下呼吸道感染（24 月龄以下）

Nurs Womens Health. 2024 Feb;28(1):75-79. doi: 10.1016/j.nwh.2023.11.002. Epub 2023 Dec 6.

Maternal Respiratory Syncytial Virus Vaccination and Receipt of Respiratory Syncytial Virus Antibody (Nirsevimab) by Infants Aged <8 Months - United States, April 2024.母亲接种呼吸道合胞病毒疫苗和 8 月龄以下婴儿接种呼吸道合胞病毒抗体（Nirsevimab）-美国，2024 年 4 月。

MMWR Morb Mortal Wkly Rep. 2024 Sep 26;73(38):837-843. doi: 10.15585/mmwr.mm7338a2.

Assessment of effectiveness and impact of universal prophylaxis with nirsevimab for prevention of hospitalizations due to respiratory syncytial virus in infants. The NIRSE-GAL study protocol.评价尼赛珠单抗对预防婴儿因呼吸道合胞病毒住院的普遍预防的有效性和影响。NIRSE-GAL 研究方案。

Hum Vaccin Immunother. 2024 Dec 31;20(1):2348135. doi: 10.1080/21645515.2024.2348135. Epub 2024 May 13.

The effectiveness of nirsevimab in reducing the burden of disease due to respiratory syncytial virus (RSV) infection over time in the Madrid region (Spain): a prospective population-based cohort study.尼赛珠单抗在马德里地区（西班牙）随时间推移降低呼吸道合胞病毒（RSV）感染疾病负担的效果：一项基于人群的前瞻性队列研究。

Front Public Health. 2024 Aug 16;12:1441786. doi: 10.3389/fpubh.2024.1441786. eCollection 2024.

Effectiveness and impact of universal prophylaxis with nirsevimab in infants against hospitalisation for respiratory syncytial virus in Galicia, Spain: initial results of a population-based longitudinal study.尼赛珠单抗在西班牙加利西亚为婴儿进行普遍预防对呼吸道合胞病毒住院治疗的效果和影响：一项基于人群的纵向研究的初步结果。

Lancet Infect Dis. 2024 Aug;24(8):817-828. doi: 10.1016/S1473-3099(24)00215-9. Epub 2024 Apr 30.

Use of Nirsevimab for the Prevention of Respiratory Syncytial Virus Disease Among Infants and Young Children: Recommendations of the Advisory Committee on Immunization Practices - United States, 2023.《使用尼赛珠单抗预防婴幼儿呼吸道合胞病毒疾病：免疫实践咨询委员会的建议-美国，2023 年》。

MMWR Morb Mortal Wkly Rep. 2023 Aug 25;72(34):920-925. doi: 10.15585/mmwr.mm7234a4.

本文引用的文献

Lancet Infect Dis. 2024 Aug;24(8):817-828. doi: 10.1016/S1473-3099(24)00215-9. Epub 2024 Apr 30.

Potential Effects on Elderly People From Nirsevimab Use in Infants.在婴儿中使用尼塞韦单抗对老年人的潜在影响。

Open Respir Arch. 2024 Mar 23;6(2):100320. doi: 10.1016/j.opresp.2024.100320. eCollection 2024 Apr-Jun.

Early estimates of nirsevimab immunoprophylaxis effectiveness against hospital admission for respiratory syncytial virus lower respiratory tract infections in infants, Spain, October 2023 to January 2024.2023 年 10 月至 2024 年 1 月，西班牙对婴儿呼吸道合胞病毒下呼吸道感染住院进行 nirsevimab 免疫预防的早期效果评估。

Euro Surveill. 2024 Feb;29(6). doi: 10.2807/1560-7917.ES.2024.29.6.2400046.

The epidemiology of medically attended respiratory syncytial virus in older adults in the United States: A systematic review.美国老年人中就医的呼吸道合胞病毒流行病学：一项系统综述。

PLoS One. 2017 Aug 10;12(8):e0182321. doi: 10.1371/journal.pone.0182321. eCollection 2017.

Respiratory syncytial virus as a cause of acute respiratory infections in adults. An emerging disease?

Rev Clin Esp (Barc). 2015 Oct;215(7):418-9. doi: 10.1016/j.rce.2015.03.002. Epub 2015 May 5.

[Respiratory infections caused by respiratory syncytial virus in the adult population: description of 16 cases].[成人呼吸道合胞病毒引起的呼吸道感染：16例病例描述]

Med Clin (Barc). 2013 Aug 17;141(4):163-6. doi: 10.1016/j.medcli.2013.05.012. Epub 2013 Jul 5.

Natural reinfection of adults by respiratory syncytial virus. Possible relation to mild upper respiratory disease.成人呼吸道合胞病毒自然再感染。与轻度上呼吸道疾病的可能关系。

N Engl J Med. 1962 Jul 12;267:68-72. doi: 10.1056/NEJM196207122670204.

Mortality associated with influenza and respiratory syncytial virus in the United States.美国与流感和呼吸道合胞病毒相关的死亡率。

JAMA. 2003 Jan 8;289(2):179-86. doi: 10.1001/jama.289.2.179.

An outbreak of respiratory syncytial virus infection in an old people's home.一家养老院发生呼吸道合胞病毒感染疫情。

J Infect. 1984 May;8(3):259-61. doi: 10.1016/s0163-4453(84)94075-1.

Respiratory syncytial virus infections in adults.成人呼吸道合胞病毒感染

Am Rev Respir Dis. 1987 Sep;136(3):561-4. doi: 10.1164/ajrccm/136.3.561.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

[Impact in the adult population of immunization with nirsevimab in children under 6 months of age against respiratory syncytial virus].

作者信息

机构信息

出版信息

相似文献

本文引用的文献

文献AI研究员

用中文搜PubMed

文档翻译

Suppr 超能文献

相似文献

本文引用的文献